• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽对神经母细胞瘤生长的自身调节

Autoregulation of neuroblastoma growth by vasoactive intestinal peptide.

作者信息

Pence J C, Shorter N A

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC.

出版信息

J Pediatr Surg. 1992 Aug;27(8):935-43; discussion 944. doi: 10.1016/0022-3468(92)90536-g.

DOI:10.1016/0022-3468(92)90536-g
PMID:1328588
Abstract

Elevated serum levels of vasoactive intestinal peptide (VIP) are associated with some cases of neuroblastoma and correlate with a favorable prognosis. VIP has previously been shown in our laboratory to cause the in vitro growth inhibition and morphological differentiation of the human neuroblastoma cell line, LA-N-5. It is now shown that LA-N-5 cells express immunoreactive VIP and bear specific VIP receptors. Antagonism of endogenous VIP, either by competitive inhibition or receptor blockade, increased cell proliferation, suggesting that VIP is operative in normal growth regulation. Intracellular and extracellular levels of VIP were also shown to increase significantly during the retinoic acid-induced differentiation of these cells. Furthermore, a concomitant marked increase in VIP receptor expression was demonstrated with cellular differentiation. These receptors remain functional as evidenced by a matching increase in the level of detectable cAMP generated in response to exogenous VIP. It is concluded that VIP is a normal autoregulator of neuroblastoma cell growth and differentiation, and that retinoic acid-mediated differentiation may be, in part, due to endogenous VIP.

摘要

血清中血管活性肠肽(VIP)水平升高与某些神经母细胞瘤病例相关,且与良好的预后相关。此前在我们实验室已表明,VIP可导致人神经母细胞瘤细胞系LA-N-5在体外生长受抑制并发生形态分化。现已表明,LA-N-5细胞表达免疫反应性VIP并带有特异性VIP受体。通过竞争性抑制或受体阻断对内源性VIP进行拮抗,可增加细胞增殖,这表明VIP在正常生长调节中起作用。在这些细胞的视黄酸诱导分化过程中,细胞内和细胞外的VIP水平也显著增加。此外,随着细胞分化,VIP受体表达明显增加。这些受体仍然具有功能,这可通过对外源VIP产生的可检测cAMP水平的相应增加得到证明。结论是,VIP是神经母细胞瘤细胞生长和分化的正常自动调节因子,视黄酸介导的分化可能部分归因于内源性VIP。

相似文献

1
Autoregulation of neuroblastoma growth by vasoactive intestinal peptide.血管活性肠肽对神经母细胞瘤生长的自身调节
J Pediatr Surg. 1992 Aug;27(8):935-43; discussion 944. doi: 10.1016/0022-3468(92)90536-g.
2
The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation.
Arch Surg. 1993 May;128(5):591-5. doi: 10.1001/archsurg.1993.01420170127020.
3
Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y.
FEBS Lett. 1989 Jul 3;250(2):611-4. doi: 10.1016/0014-5793(89)80806-3.
4
Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.通过上调人1型血管活性肠肽受体抑制神经母细胞瘤细胞的致瘤性。
Regul Pept. 2002 Nov 15;109(1-3):155-65. doi: 10.1016/s0167-0115(02)00199-4.
5
Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
Regul Pept. 1992 Feb 18;37(3):213-26. doi: 10.1016/0167-0115(92)90616-3.
6
Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells.维甲酸对神经母细胞瘤细胞中血管活性肠肽基因表达影响的特征分析。
Endocrinology. 1994 Oct;135(4):1455-63. doi: 10.1210/endo.135.4.7925107.
7
In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide.血管活性肠肽引起的人神经母细胞瘤细胞的体外分化
Cancer Res. 1990 Aug 15;50(16):5177-83.
8
Functional vasoactive intestinal polypeptide (VIP) receptors in human neuroblastoma subclones that contain VIP precursor mRNA and release VIP-like substances.人神经母细胞瘤亚克隆中含有血管活性肠肽(VIP)前体mRNA并释放类VIP物质的功能性VIP受体。
J Biol Chem. 1989 Mar 5;264(7):3647-50.
9
Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.血管活性肠肽可降低MYCN的表达,并在人MYCN扩增的神经母细胞瘤细胞系中与视黄酸协同作用。
Int J Oncol. 2008 Nov;33(5):1081-9.
10
Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells.人神经母细胞瘤细胞中血管活性肠肽(VIP)在mRNA和肽水平上的独特调控。
Neurosci Lett. 1992 May 25;139(2):213-6. doi: 10.1016/0304-3940(92)90555-l.

引用本文的文献

1
SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.分化的SH-SY5Y细胞中SSR2(a)受体表达及肾上腺素能/胆碱能特性
Neurochem Res. 2003 Apr;28(3-4):449-60. doi: 10.1023/a:1022848718109.
2
Characterization of the rat vasoactive intestinal polypeptide receptor gene 5' region.大鼠血管活性肠肽受体基因5'区域的特征分析
Biochem J. 1995 Jun 15;308 ( Pt 3)(Pt 3):719-23. doi: 10.1042/bj3080719.
3
Inhibition of human neuroblastoma growth by a specific VIP antagonist.
J Mol Neurosci. 1994;5(4):231-9. doi: 10.1007/BF02736724.